Related Experiment Video
Updated: Sep 13, 2025

Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
Immune Thrombocytopenia Triggered by Sildenafil-Containing Rhino 69 Platinum 1000: A Case Report
Aishwarya Saripalli1, Rupam Sharma1, Kevin T Dao1
1Internal Medicine, Kern Medical Center, Bakersfield, USA.
None:
Drug-induced immune thrombocytopenia (DITP) is a rare but serious complication resulting from exposure to certain medications, herbal products, and dietary supplements. Although various agents have been implicated, sildenafil-containing over-the-counter supplements have not previously been associated with this phenomenon. Herein, we report a case of a 24-year-old male who presented with diffuse purpuric rash, gum bleeding, and epistaxis over three days. Laboratory testing revealed severe isolated thrombocytopenia (platelet count of 4,000/µL). Extensive workup for infectious, hepatic, autoimmune, and thrombotic etiologies was unremarkable. Upon further history, the patient disclosed use of "Rhino 69 Platinum 1000," an unregulated sexual enhancement supplement containing undeclared sildenafil over the prior two weeks. He received intravenous immunoglobulin (IVIG) and high-dose dexamethasone with a rapid platelet recovery. After discontinuing the supplement, his platelet counts normalized, and he remained symptom-free during one year of follow-up. No other cause of thrombocytopenia was identified. This report highlights a probable case of DITP associated with the use of "Rhino 69 Platinum 1000." To our knowledge, this is a rare reported case implicating this supplement or sildenafil as a potential trigger for DITP.
More Related Videos
08:46Dose Uptake of Platinum- and Ruthenium-based Compound Exposure in Zebrafish by Inductively Coupled Plasma Mass Spectrometry with Broader Applications
Published on: April 21, 2022
08:13Mitigation of Blood Borne Cell Attachment to Metal Implants through CD47-Derived Peptide Immobilization
Published on: December 3, 2020
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.